Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432479 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief
A NA study of Infantile Colic, sponsored by The Archer-Daniels-Midland Company.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT05432479 is a NA study of Infantile Colic that is actively recruiting participants, run by The Archer-Daniels-Midland Company. The registered enrollment target is 80 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05432479, a NA study of Infantile Colic, is actively recruiting participants, sponsored by The Archer-Daniels-Midland Company.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates the efficacy of single strain probiotic administered in a form of a sachet in the treatment of infant colic in infants 3-12 weeks old.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Probiotic
Study Locations (2)
Illinois
- Atlantia Food Clinical Trials - Chicago
Maharashtra
- Pulse Multispeciality Hospital, - Pune
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05432479
The ClinicalTrials.gov registry entry for NCT05432479 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Archer-Daniels-Midland Company, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infantile Colic appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05432479 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Maharashtra.
Frequently Asked Questions
What is clinical trial NCT05432479 about?
NCT05432479 is a clinical study titled "Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief". This study evaluates the efficacy of single strain probiotic administered in a form of a sachet in the treatment of infant colic in infants 3-12 weeks old.
What is the current status of trial NCT05432479?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-09-30. Estimated completion is 2026-05.
What conditions does trial NCT05432479 study?
This clinical trial studies the following conditions: Infantile Colic.
What interventions are being tested in trial NCT05432479?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05432479?
This trial is sponsored by The Archer-Daniels-Midland Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05432479 being conducted?
This trial has 2 study locations across Illinois, Maharashtra. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.